EpiBiologics Funding: $50M Raised, Series A (2023)
EpiBiologics is a Biotech company based in San Mateo, California. It has raised $50M in total funding. Latest round: Series A.
EpiBiologics funding overview
EpiBiologics is a Biotech company based in San Mateo, California. EpiBiologics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for EpiBiologics runs through 2023; nothing later has been disclosed. Investors on record include Mubadala Capital, Polaris Partners, Vivo Capital, GV. 4 distinct backers are named across the disclosed rounds.
EpiBiologics at a glance
Total raised
$50M
Latest round
Series A
Latest round date
March 2023
Industry
Biotech
Headquarters
San Mateo, California
Notable investors
Mubadala Capital, Polaris Partners, Vivo Capital, GV
Frequently asked about EpiBiologics funding
How much has EpiBiologics raised?
EpiBiologics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in EpiBiologics?
Mubadala Capital, Polaris Partners, Vivo Capital, GV are named among the investors backing EpiBiologics.
What was the latest EpiBiologics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is EpiBiologics based?
EpiBiologics is based in San Mateo, California.
What sector does EpiBiologics operate in?
EpiBiologics is tracked under Biotech from San Mateo, California, with $50M in disclosed funding.
When did EpiBiologics last raise?
The last disclosed EpiBiologics round closed in March 2023 at Series A.
EpiBiologics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Mateo below to benchmark round size and investor mix.
